Displaying 1 drug
Tigecycline
Tigecycline is a glycylcycline antibiotic developed and marketed by Wyeth under the brand name Tygacil. It was developed in response to the growing prevalence of antibiotic resistance in bacteria such as Staphylococcus aureus. It was granted fast-track approval by the U.S. Food and Drug Administration (FDA) on June 17, 2005.
Approved
Matched Products: … Tigelat 50mg (Tigecycline Lyophilised Powder for Intravenous Infusion 50mg/Vial) …
Displaying 1 drug